menu
    • menu

    Company profile for Avenzo Therapeutics

    NEW Drugs in Dev: 4
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Sharp is a leader in commercial packaging, clinical services, and sterile manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    As a CDMO, Mikart offers integrated CDMO services for Solid Dose & Non-sterile Liquid formulations.

    Virtual Booth

    Contact Supplier

    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Avenzo Therapeutics, established in 2022 and co-founded by Dr. Athena Countouriotis and Dr. Mohammad Hirmand, is a clinical-stage biotechnology firm. Our primary focus is on developing and advancing a robust pipeline of oncology therapies with the aim of being among the best in their class. These therapies are designed to target cell cycle control mechanisms, with the goal of halting the abnormal proliferation of cells that is...
    Avenzo Therapeutics, established in 2022 and co-founded by Dr. Athena Countouriotis and Dr. Mohammad Hirmand, is a clinical-stage biotechnology firm. Our primary focus is on developing and advancing a robust pipeline of oncology therapies with the aim of being among the best in their class. These therapies are designed to target cell cycle control mechanisms, with the goal of halting the abnormal proliferation of cells that is characteristic of many types of cancer. Our team boasts a proven track record within the industry for developing oncology treatments that hold promise in significantly impacting patients' lives for the better.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Avenzo TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Suite 200, San Diego, CA 92130
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://avenzotx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/avenzotx/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Avenzo Advances Dual CDK4/CDK2 Combo in Breast Cancer Study
    Avenzo Advances Dual CDK4/CDK2 Combo in Breast Cancer Study

    28 Apr 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-04-28/avenzo-therapeutics-advances-the-combination-of-cdk4-selective-inhibitor-avzo-023-with-cdk2-select

    PHARMIWEB
    28 Apr 2026
    Share Share
    Avenzo Therapeutics To Unveil AVZO-021, Phase 1 Study Results
    Avenzo Therapeutics To Unveil AVZO-021, Phase 1 Study Results

    21 Apr 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-04-21/avenzo-therapeutics-to-present-updated-results-from-the-phase-1-study-of-avzo-021-a-potential-best

    PHARMIWEB
    21 Apr 2026
    Share Share
    Avenzo Therapeutics Unveils AVZO-021 Data at SABCS 2025
    Avenzo Therapeutics Unveils AVZO-021 Data at SABCS 2025

    11 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251211085624/en/Avenzo-Therapeutics-Presents-Initial-Results-from-the-Phase-12-Study-of-AVZO-021-a-Potential-Best-in-Class-CDK2-Inhibitor-at-the-2025-San-Antonio-Breast-Cancer-Symposium

    BUSINESSWIRE
    11 Dec 2025
    Share Share
    Avenzo Therapeutics Gains Fast Track for AVZO-103
    Avenzo Therapeutics Gains Fast Track for AVZO-103

    24 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251124173033/en/Avenzo-Therapeutics-Granted-Fast-Track-Designation-for-AVZO-103-a-Potential-Best-in-Class-Nectin4TROP2-Bispecific-Antibody-Drug-Conjugate-for-the-Treatment-of-Patients-with-Urothelial-Cancer-Previously-Treated-with-Enfortumab-Vedotin

    BUSINESSWIRE
    24 Nov 2025
    Share Share
    Avenzo Therapeutics Names Scott Lipman as CFO
    Avenzo Therapeutics Names Scott Lipman as CFO

    19 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251119935505/en/Avenzo-Therapeutics-Announces-Appointment-of-Scott-Lipman-as-Chief-Financial-Officer

    BUSINESSWIRE
    19 Nov 2025
    Share Share
    Avenzo Therapeutics Receives Fast Track For AVZO-1418
    Avenzo Therapeutics Receives Fast Track For AVZO-1418

    10 Nov 2025

    // BUSINESS WIRE

    https://www.businesswire.com/news/home/20251110260582/en/Avenzo-Therapeutics-Granted-Fast-Track-Designation-for-AVZO-1418-a-Potential-Best-in-Class-EGFRHER3-Bispecific-Antibody-Drug-Conjugate-for-the-Treatment-of-Patients-with-EGFR-Mutated-TKI-Pretreated-NSCLC

    BUSINESS WIRE
    10 Nov 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search